Novel, potent and selective anilinoquinazoline and anilinopyrimidine inhibitors of p38 MAP kinase

被引：62

作者：

Cumming, JG ^{[1
]}

McKenzie, CL ^{[1
]}

Bowden, SG ^{[1
]}

Campbell, D ^{[1
]}

Masters, DJ ^{[1
]}

Breed, J ^{[1
]}

Jewsbury, PJ ^{[1
]}

机构：

[1] AstraZeneca, Macclesfield SK10 4TG, Cheshire, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2004年 / 14卷 / 21期

关键词：

p38 MAP kinase inhibitors;

D O I：

10.1016/j.bmcl.2004.08.007

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

SAR studies led to the identification of 4-(3-benzoylamino-6-methyl-anilino)quinazolines as potent and selective inhibitors of p38 MAP kinase. Further optimisation led to the identification of a series of 4-(3-benzoylamino-6-methyl-anilino)pyr midines as potent inhibitors of the p38 MAP kinase signalling pathway in vitro and in vivo. (C) 2004 Elsevier Ltd. All rights reserved.

引用

页码：5389 / 5394

页数：6

共 28 条

[1] Protein kinase activation and myocardial ischemia/reperfusion injury
Armstrong, SC
[J]. CARDIOVASCULAR RESEARCH, 2004, 61 (03) : 427 - 436
[2] Studies leading to the identification of ZD1839 (Iressa™):: An orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer
Barker, AJ
Gibson, KH
Grundy, W
Godfrey, AA
Barlow, JJ
Healy, MP
Woodburn, JR
Ashton, SE
Curry, BJ
Scarlett, L
Henthorn, L
Richards, L
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (14) : 1911 - 1914
[3] New inhibitors of p38 kinase
Boehm, JC
Adams, JL
[J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (01) : 25 - 37
[4] Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 2: Identification and optimisation of substituted 2,4-bis anilino pyrimidines
Breault, GA
Ellston, RPA
Green, S
James, SR
Jewsbury, PJ
Midgley, CJ
Pauptit, RA
Minshull, CA
Tucker, JA
Pease, JE
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (18) : 2961 - 2966
[5] A novel series of p38 MAP kinase inhibitors for the potential treatment of rheumatoid arthritis
Brown, DS
Belfield, AJ
Brown, GR
Campbell, D
Foubister, A
Masters, DJ
Pike, KG
Snelson, WL
Wells, SL
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (21) : 5383 - 5387
[6] Cirillo Pier F., 2002, Current Topics in Medicinal Chemistry, V2, P1021, DOI 10.2174/1568026023393390
[7] CUMMING JG, 2000, Patent No. 0127089
[8] Specificity and mechanism of action of some commonly used protein kinase inhibitors
Davies, SP
Reddy, H
Caivano, M
Cohen, P
[J]. BIOCHEMICAL JOURNAL, 2000, 351 (351) : 95 - 105
[9] Potential new drugs for therapy of chronic obstructive pulmonary disease
de Boer, WI
[J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (07) : 1067 - 1086
[10] Structural basis for p38α MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity
Fitzgerald, CE
Patel, SB
Becker, JW
Cameron, PM
Zaller, D
Pikounis, VB
O'Keefe, SJ
Scapin, G
[J]. NATURE STRUCTURAL BIOLOGY, 2003, 10 (09) : 764 - 769

← 1 2 3 →